NexturnBioscience Co. Ltd (089140) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.019x

Based on the latest financial reports, NexturnBioscience Co. Ltd (089140) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.51 Billion ≈ $3.06 Million USD) by net assets (₩240.26 Billion ≈ $162.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 089140 equity financing ratio to measure how much of total assets are equity-financed.

NexturnBioscience Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how NexturnBioscience Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check NexturnBioscience Co. Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

NexturnBioscience Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NexturnBioscience Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Condor Resources Inc V:CN	-0.021x
Domo Activos Socimi SA MC:DOMO	-0.014x
Firefly Neuroscience, Inc. NASDAQ:AIFF	-0.154x
Rubberex Corporation M Bhd KLSE:7803	0.038x
BEYOND MED TEC. INC. NEW F:7FM	N/A
All In! Games S.A. WAR:ALG	-0.030x
Betonjaya Manunggal Tbk JK:BTON	0.062x
Brite Tech Bhd KLSE:0011	0.060x

Annual Cash Flow Conversion Efficiency for NexturnBioscience Co. Ltd (2014–2024)

The table below shows the annual cash flow conversion efficiency of NexturnBioscience Co. Ltd from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see NexturnBioscience Co. Ltd (089140) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩136.62 Billion ≈ $92.59 Million	₩-1.14 Billion ≈ $-774.60K	-0.008x	+41.40%
2023-12-31	₩138.01 Billion ≈ $93.53 Million	₩-1.97 Billion ≈ $-1.34 Million	-0.014x	-29.82%
2022-12-31	₩108.27 Billion ≈ $73.38 Million	₩-1.19 Billion ≈ $-806.98K	-0.011x	-127.83%
2021-12-31	₩92.73 Billion ≈ $62.85 Million	₩3.66 Billion ≈ $2.48 Million	0.040x	+1520.67%
2020-12-31	₩96.77 Billion ≈ $65.58 Million	₩235.94 Million ≈ $159.89K	0.002x	-91.07%
2019-12-31	₩100.16 Billion ≈ $67.88 Million	₩2.74 Billion ≈ $1.85 Million	0.027x	-72.91%
2018-12-31	₩95.51 Billion ≈ $64.73 Million	₩9.63 Billion ≈ $6.52 Million	0.101x	+81.94%
2017-12-31	₩91.77 Billion ≈ $62.19 Million	₩5.08 Billion ≈ $3.45 Million	0.055x	-72.15%
2016-12-31	₩89.89 Billion ≈ $60.92 Million	₩17.88 Billion ≈ $12.12 Million	0.199x	+211.78%
2015-12-31	₩30.04 Billion ≈ $20.36 Million	₩1.92 Billion ≈ $1.30 Million	0.064x	-71.37%
2014-12-31	₩29.08 Billion ≈ $19.70 Million	₩6.48 Billion ≈ $4.39 Million	0.223x	--

About NexturnBioscience Co. Ltd

KQ:089140 Korea Machinery, Tools, Heavy Vehicles, Trains & Ships

Market Cap

$15.20 Million

₩22.43 Billion KRW

Market Cap Rank

#25906 Global

#1932 in Korea

Share Price

₩2150.00

Change (1 day)

+6.97%

52-Week Range

₩1853.00 - ₩2995.00

All Time High

₩56500.00